In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
BioMed X to establish first US-based research institute in New Haven
New Haven Biz
BioMed X, a biomedical research institute in Germany, is launching its first U.S. facility here in New Haven. The BioMed X Institute in New Haven will focus on research in the areas of immunology and tissue engineering.
German Biomed Researchers Pick New Haven For U.S. Post
New Haven Independent
A German biomedical research institute is putting down roots in New Haven, with newly announced plans to move into a local lab space later this year as it partners with a biopharmaceutical company to study immunology and tissue engineering. That research firm is called BioMed X.
BioMed X Extends Research Collaboration With AbbVie On Immunology And Tissue Engineering
RTT News/Nasdaq
BioMed X noted that the new US-based research collaboration will focus on immunology and tissue engineering, following a first joint research project on Alzheimer’s disease at the BioMed X Institute in Heidelberg, Germany.
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie
BioSpace
“Extending our successful partnership with AbbVie to our new site in the US is a big milestone for our institute,” said Christian Tidona, Founder and Managing Director of BioMed X.
BioMed X and AbbVie Extend Research Collaboration in the US
Street Insider
BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut.
BioMed X and AbbVie Extend Research Collaboration in the US
FinanzNachrichten
BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut.
New Haven Biosciences Ecosystem News: BioMed X and AbbVie Extend Research Collaboration in the US
Yale Ventures
“Yale is devoted to academic leadership as well as global strategic partnerships to foster innovation and an entrepreneurial spirit. We welcome BioMed X to our biosciences community and appreciate the opportunities this alliance ushers in, including cooperation with international industry partners and networking with the European biotech ecosystem,” said Josh Geballe, Managing Director at Yale Ventures.
BioMed X and AbbVie Extend Research Collaboration in the US
Advance CT
BioMed X announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut. The new US-based research collaboration will focus on immunology and tissue engineering.